Skip to main content
SpringerLink
Log in

Insulin glargine

lower risk of hypoglycaemia in diabetes

  • Newsletter Article
  • Published:
Inpharma Weekly

Abstract

Once-daily insulin glargine [HOE 901] effectively controls blood glucose levels in patients with type 1 and 2 diabetes mellitus and is associated with a lower risk of hypoglycaemia, according to the results of studies presented at the 35th Annual Meeting of the European Association for the Study of Diabetes [ Brussels, Belgium; September-October 1999 ].

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Carmen Innes
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Innes, C. Insulin glargine. Inpharma Wkly. 1217, 9–10 (1999). https://doi.org/10.2165/00128413-199912170-00017

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-199912170-00017

Keywords

Search

Navigation